Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from an analysis of 160 real-world patients with ...

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter ...

The development and progression of cancer is accompanied by complex changes in patterns of gene expression. In the USA, malignant neoplasms of the skin are the most common cancers of humankind.

About Surmodics, Inc. Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay ...

Reviewed by Dr. Tomislav Meštrović, MD, Ph.D. Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) ...